<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01182792</url>
  </required_header>
  <id_info>
    <org_study_id>CMS</org_study_id>
    <nct_id>NCT01182792</nct_id>
  </id_info>
  <brief_title>Chronic Mountain Sickness, Systemic Vascular Function</brief_title>
  <acronym>CMS</acronym>
  <official_title>Chronic Hypoxemia and Systemic Vascular Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Lausanne Hospitals</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Instituto Boliviano de Biologia de Altura</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Universitad Major de S. Andres, La Paz, Bolivia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Lausanne Hospitals</source>
  <brief_summary>
    <textblock>
      Diseases associated with chronic hypoxemia like chronic obstructive pulmonary disease (COPD)
      or emphysema, represent major medical and socio-economical problems and one of the leading
      cause of morbidity and mortality in the western countries. Recently, is has been shown that
      cardiovascular (CV) diseases contribute highly to the morbidity and mortality of these
      patients. Furthermore, increasing evidence suggest that systemic vascular dysfunction play a
      central role in the mediation of the increased CV risk in patients with COPD. However the
      underlying mechanisms of vascular dysfunction in these patients are incompletely understood.
      Chronic mountain sickness (CMS) is characterized by chronic hypoxemia related at least in
      part to hypoventilation; it affects relatively young adults, and may therefore allow to study
      the effects of chronic hypoxemia. The investigators therefore will assess systemic vascular
      function and test the hypothesis that increased oxidative stress is responsible for this
      dysfunction. Since polyglobulia is a hallmark of chronic hypoxemia and has been suggested to
      affect vascular function, the investigators will test the effects of hemodilution on vascular
      function. Then, the investigators will test the effects of acute oxygen application and 1
      month antioxidative dietary supplement on vascular function.

      Preliminary data suggest that offspring of CMS patients may display pulmonary and systemic
      vascular dysfunction. Antioxidant administration is know to improve vascular function. We
      will test the acute effect of Vitamin C in this setting.

      Finally, since there is considerable inter-individual variability of pulmonary artery
      pressure among CMS patients and the presence of a patent foramen ovale (PFO)is increased in
      clinical conditions associated with pulmonary hypertension and hypoxemia, we will assess the
      prevalence of PFO in healthy high altitude dwellers and in CMS patients and its effects on
      pulmonary artery pressure at rest and during mild exercise.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>October 2008</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">September 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Endothelial Function</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Mountain Sickness</condition>
  <condition>Chronic</condition>
  <arm_group>
    <arm_group_label>Antioxidant</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin C and E</intervention_name>
    <description>1 month, 1g Vitamin C and 400 IE Vitamin E or Acute, 1g Vitamin C (in the offspring)</description>
    <arm_group_label>Antioxidant</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>1 month Placebo</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with Chronic Mountain Sickness and their offspring

        Exclusion Criteria:

          -  Smoking

          -  Lung disease

          -  Arterial Hypertension
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Istituto Boliviano de Biologia de Altura, Universitad S. Andres</name>
      <address>
        <city>La Paz</city>
        <country>Bolivia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Lausanne, Botnar Center for Extreme Medicine</name>
      <address>
        <city>Lausanne</city>
        <state>Vaud</state>
        <zip>1011</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Bolivia</country>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 16, 2010</study_first_submitted>
  <study_first_submitted_qc>August 16, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 17, 2010</study_first_posted>
  <last_update_submitted>September 5, 2013</last_update_submitted>
  <last_update_submitted_qc>September 5, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 6, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Lausanne Hospitals</investigator_affiliation>
    <investigator_full_name>Urs Scherrer</investigator_full_name>
    <investigator_title>Prof</investigator_title>
  </responsible_party>
  <keyword>Endothelial Function</keyword>
  <keyword>Chronic Hypoxia</keyword>
  <keyword>Oxidative Stress</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Altitude Sickness</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Ascorbic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

